Key result
Traditional risk factors initiate early atherosclerotic bone formation, defining a critical therapeutic window before severe calcification.
Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
May inform early risk factor control in osteocardiology; leaves open the precise therapeutic window pending prospective validation.
Recent epidemiological studies have revealed that the risk factors associated with coronary artery calcification (CAC), including male gender, smoking, hypertension, and elevated serum cholesterol, are similar to the risk factors associated with the development of calcific aortic valve disease (CAVD). The results of the experimental and clinical studies demonstrate that traditional risk factors initiate early atherosclerosis which over time differentiates to form bone in the heart causing clinical CAC and CAVD. Understanding the cellular mechanisms of cardiovascular calcification, the end-stage process of the atherosclerosis will help define the specific time point to modify this cellular process of bone formation in the heart termed osteocardiology. This time point between subclinical atherosclerosis and clinical calcification is the go/no-go time point, or the point of no return with severe clinical calcification in the heart. This review will summarize the development of bone formation in the heart termed osteocardiology, to define the go/no-go time point for therapy initiation to slow the progression of cardiovascular calcification.
No takes yet. Share an insight, caveat, or question.
Nalini M. Rajamannan (2018) studied this question. Traditional risk factors initiate early atherosclerosis that differentiates into cardiac bone formation, defining a critical therapeutic window before severe clinical calcification occurs.
Synapse has enriched 10 related papers. Consider them for comparative context: